Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Migraine and 5-HT


Published on

This is an overview of drugs used to treat migraine with an emphasis on serotonergic drugs. This presentation was for 2nd year pharmacy students as part of a pharmacology & toxicology course and accompanies Goodman & Gilman's (12e) chapter 46. A bit of general background on 5-HT is also included.

  • Be the first to comment

Migraine and 5-HT

  1. 1. Serotonin & Migraine Brian J. Piper, Ph.D., M.S.
  2. 2. Goals• Serotonin – Biosynthesis & elimination – Receptors• Migraine – ergotamines – triptans
  3. 3. Serotonin in Different SpeciesC. Elegans (roundworm) Betta splendens (Siamese fighting fish) lobster C57 mouse Long-Evans rat marmoset
  4. 4. Biosynthesis: Tryptophan • Essential amino acid Food g tryptophan / 100 g food salami 0.253 lentils 0.251 turkey (breast) 0.194 almonds 0.192 walnuts 0.17 asparagus 0.027USDA National Nutrient Database for Standard Reference, Release 19 (2006).
  5. 5. Biosynthesis of 5-Hydroxytryptamine• Tryptophan hydroxylase: found in axons, rate limiting step• L-aromatic amino acid decarboxylase (AACD): not rate limiting step, also important for catecholamine General Rule: Depleting 5-HT: easy Increasing 5-HT: not easy
  6. 6. Where is 5-Hydroxytryptamine (Serotonin) localized?• Enterochromaffin cells (90%)• Platelets: thombosis• Central nervous system (10%) – Dorsal raphe: forebrain (lateral) – Medial raphe: forebrain (medial) – Nucleus raphe magnus: spinal cord Kranz et al. (2012). PNAS, 109(29), e2000.
  7. 7. 5-HT & Aggression • Para-chlorophenylalanine (PCPA): irreversible tryptophan hydroxylase inhibitor • PCPA treated rats were tested for muricide • Inverse relationship between 5-HT & aggression Killers Non-killers Control 0 13 PCPA 14 4Paxinos et al. (1977). Pharmacology, Biochemistry, Behavior, 6, 439-447.
  8. 8. Serotonin Transporter • SERT removes 5-HT from synapse • Localized at cleft, along axon, & on somaStahl (2008). Essential Psychopharmacology. p. 93.
  9. 9. Serotonin Transporter (SERT) Reflects Axon Integrity• High dose 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) damages 5-HT axons• SERT can be measured with immunocytochemistry
  10. 10. Serotonin fibers in the caudate nucleus of a control squirrel monkey (A), a monkey that received 5 mg/kg MDMA 2 weeks (B), or 7 years (C) previously.Hatzidimitriou et al. (1999). Journal of Neuroscience, 19, 5096-5107.
  11. 11. Breakdown of 5-Hydroxytryptamine Monoamine Oxidase (MAO): target of older antidepressant drugs 5-HIAA: found in Cerebral Spinal Fluid NADH: nicotine adenine dinucleotide, reduced; increased by ethanol!Sanders-Bush & Hazelwood (2012). In Pharmacological Basis of Therapeutics, p. 336.
  12. 12. Ergot Poisoning • Fungus (Claviceps purpurea) found on grain contains ergotamine • Antiquity: Saint Anthony’s fire (convulsions & gangerine) • Modern Case: Pont St. Espirit, France 1951 – Early Symptoms (6-48 hours): diffuse abdominal pain (burning sensation throughout whole digestive tract), nausea, vomiting, insomnia lasting several days – Middle Symptoms ( ≈2 days – 1 week): cold extremities, cramps of calves, logorrhea, visual hallucinations (themes = animal & self-accusation) – Late Symptoms (≈post 1 week): muscular spasm & cardiovascular collapse (4 died)Summarized from Gabbai et al. (1951). British Medical Journal, Sept 15, 650-651.
  13. 13. History of LSD• Lysergic acid diethylamide was synthesized by Hoffman (1938) from ergotamine• CIA explored use (1950s)• Counter-culture use (1960s) Albert Hoffman, Ph.D.• 5-HT2A antagonist• Schedule I• Adjunct to psychotherapy? 1906 - 2008
  14. 14. History of LSD • Lysergic acid diethylamide was synthesized by Hoffman (1938) from ergotamine • CIA explored use (1950s) • Counter-culture use (1960s) • 5-HT2A antagonist/5-HT1A agonist • Schedule I • Adjunct to psychotherapy?1st 3 min:
  15. 15. 5-HT Receptor Tissue Post-Receptor Agonist (Ag) or Mechanism Antagonist (Ant) 1A Raphe, hippocampus Gi Ag: 8-OH-DPAT 1B substantia nigra (SN) Gi Ag: Sumatriptan 1C (oops, 2C) 1D brain Gi Ag: Sumatriptan 1E cortex, putamen Gi 1F cortex, hippocampus Gi 1P enteric nervous system Go Ant: Ranzapride 2A platelets, smooth muscle Gq Ag: DOI; Ant: Ketanserin 2B stomach fundus Gq Ag: DOI 2C Hippocampus, SN Gq Ag: DOI 3 area postrema Na+ channel Ag: ondansetronBased on Katzung et al. (2012). Basic & Clinical Pharmacology, p. 282.
  16. 16. 5-HT & Anxiety:Light Dark Test• Role of GABA or 5-HT in anxiety --------------------------------- --------------------------------------------------
  17. 17. 5-HT & Depression • Methods: 15 un-medicated women with a history of 2+ episodes of depression were on a low protein diet for 1 week, then randomly assigned to receive: – Tryptophan + : L-tryptophan (1.9 g), L-alanine (4.6 g) L-arginine (4.1 g) – Tryptophan - : L-alanine (4.6 g) L-arginine (4.1 g)Smith et al. (1997). Lancet, 349, 915-919.
  18. 18. Hamilton Depression Inventory
  19. 19. Ham-D Max Hamilton 1912-1988
  20. 20. Smith et al. (1997). Lancet, 349, 915-919.
  21. 21. Migraine Terminology • migraineurs: person who experiences migraines • aura: collection of symptoms that may precede or co-occur; typically visual, lasts less than 1 hour – positive features • scintillations: a rapidly oscillating pattern of visual distortions • photopsia: perception of flashes of light • teichopsia: spot of flickering light – negative features • scotoma: an area of diminished vision within the visual field • hemianopsia: blindness in half of the visual field, may involve one or both eyes – hemiplegic aura: occurring on one side of body – basilar type aura: aura is localized to the brainstemDiPiro et al. (2008). Pharmacotherapy: A Pathophysiologic Approach. p. 1008.
  22. 22. George Cruikshank: The Head Ache (1819)2:20:
  23. 23. International Headache Society Migraine Criteria • Migraine with aura (classic migraine) – At least 2 attacks – Aura fulfills criteria for typical aura, hemiplegic aura, or basilar type aura – Not attributed to another disorder • Migraine without aura – At least 5 attacks – Headache lasts 4 to 72 hours (untreated or successfully treated) – Headache has at least 2 characteristics • Unilateral location, pulsating quality, or moderate or severe intensity – Aggravation by or avoidance of routine physical activity (walking, climbing stairs) – During headache, at least one of the following: • Nausea, vomiting, or both • Photophobia and phonophobia – Not attributed to another disorder
  24. 24. Epidemiology
  25. 25. Pathophysiology• limited animal models• theory: genetic (50% heritable) & neurovascular• 2 min:• orthodromic: electrical potential following typical direction (soma to axon)• antidromic: electrical potential traveling in the reverse direction (axon to soma)
  26. 26. Ergot Alkaloids• Used for moderate to severe migraines (non- prophylactic) but not other pain• Vasoconstrictive agents with long history (1920s) but dirty drugs (5-HT, dopamine, adrenergic)
  27. 27. Effects of ergot derivatives on contraction of isolated segments of human basilar artery stripsremoved at surgery. All ergot derivatives are partial agonists, and all are more potent thanfull agonists, norepinephrine (NE) and serotonin (5-HT). Dihydroergotamine (DHE), ergotamine(ERG), methysergide (MS), and methylergometrine (MT).Modified from Katzung (2012). Basic & Clinical Pharmacology. p. 289.
  28. 28. Diverse ROA• ergotamine & caffeine (Cafergot): oral• ergotamine & caffeine (Migerot): suppositories• ergotamine tartrate (Ergomar): sublingual• dihydroxyergotamine mesylate (Migranol): nasal spray or injections
  29. 29. Adverse Effects• Route dependent nausea & vomiting (10-20%)• weakness• tingling of extremities (think history!)• chest pain & temporary changes in heart rate (↑↓ )
  30. 30. Contraindications• pregnant women (miscarriage risk)• coronary artery disease• should not be used simultaneously with triptans
  31. 31. Triptans• Recently developed (1990s) 5-HT1B/1D agonists act on neurons & blood vessels• First line therapy for moderate to severe migraines (non-prophylactic)• Should not be used with SSRI
  32. 32. Example Trial Evaluating Triptans * * *Effects of sumatriptan (6 mg injected subcutaneously, N=734) or placebo (N=370) on symptomsof acute migraine 60 minutes after subcutaneous injection. From Cady et al. (1991). JAMA, 265,2831-2835.
  33. 33. Summary• “neurotransmitter for all seasons”• Ergot alkaloids• Triptans
  34. 34. Melatonin
  35. 35. Goodwin (13) & Related TerminologyEnterochromaffin cells (p. 335): a type of enteroendocrine cell occuring in the epithelia lining thelumen of the digestive tract and the respiratory tracttunicate (p. 335): marine filter feeders (image, lower right)coelenterate (p. 335): outdated zoological term for 2 phyla including comb jellies (image, lowerleft) and sea anemoniespsychotomimetic (p. 337): drug that mimics elements of mental illness (psychosis)choroid plexus (p. 337): layer fo cells found in ventricles of brain that produce cerebral spinal fluidsuperior colliculus (p. 340): Latin: upper hill , anatomical structure (image, middle, see arrow)hyperacusis (p. 345): oversensitivity to certain frequencies of soundparesthesias (p. 346): sensation of tingling or burning, aka “pins & needles”asthenia (p. 346): weaknessprecordial (p. 348): pertaining to the region over the heart/stomachHorton’s syndome (p. 349): aka cluster headache, intense pain typically on one side of the head
  36. 36. Organic Chemistry (Refresher)